Tekmira Pharmaceuticals Corp. (Nasdaq: TKMR) stock surged some 20% to $17.23 Friday after an update on its Ebola treatment.
The U.S....
Tekmira Pharmaceutical (Nasdaq: TKMR) is on a roller coaster ride as investors bet on its chances to be the first drug to successfully develop...